Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Arterioscler Thromb Vasc Biol ; 35(4): 960-72, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25593132

ABSTRACT

OBJECTIVE: Marfan's syndrome is characterized by the formation of ascending aortic aneurysms resulting from altered assembly of extracellular matrix microfibrils and chronic tissue growth factor (TGF)-ß signaling. TGF-ß is a potent regulator of the vascular smooth muscle cell (VSMC) phenotype. We hypothesized that as a result of the chronic TGF-ß signaling, VSMC would alter their basal differentiation phenotype, which could facilitate the formation of aneurysms. This study explores whether Marfan's syndrome entails phenotypic alterations of VSMC and possible mechanisms at the subcellular level. APPROACH AND RESULTS: Immunohistochemical and Western blotting analyses of dilated aortas from Marfan patients showed overexpression of contractile protein markers (α-smooth muscle actin, smoothelin, smooth muscle protein 22 alpha, and calponin-1) and collagen I in comparison with healthy aortas. VSMC explanted from Marfan aortic aneurysms showed increased in vitro expression of these phenotypic markers and also of myocardin, a transcription factor essential for VSMC-specific differentiation. These alterations were generally reduced after pharmacological inhibition of the TGF-ß pathway. Marfan VSMC in culture showed more robust actin stress fibers and enhanced RhoA-GTP levels, which was accompanied by increased focal adhesion components and higher nuclear localization of myosin-related transcription factor A. Marfan VSMC and extracellular matrix measured by atomic force microscopy were both stiffer than their respective controls. CONCLUSIONS: In Marfan VSMC, both in tissue and in culture, there are variable TGF-ß-dependent phenotypic changes affecting contractile proteins and collagen I, leading to greater cellular and extracellular matrix stiffness. Altogether, these alterations may contribute to the known aortic rigidity that precedes or accompanies Marfan's syndrome aneurysm formation.


Subject(s)
Aortic Aneurysm/etiology , Cell Differentiation , Marfan Syndrome/complications , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Actins/metabolism , Aorta/metabolism , Aorta/pathology , Aortic Aneurysm/metabolism , Aortic Aneurysm/pathology , Biomarkers/metabolism , Calcium-Binding Proteins/metabolism , Case-Control Studies , Cell Line, Tumor , Collagen Type I/metabolism , Cytoskeletal Proteins/metabolism , Dilatation, Pathologic , Focal Adhesions/metabolism , Humans , Marfan Syndrome/metabolism , Marfan Syndrome/pathology , Microfilament Proteins/metabolism , Muscle Proteins/metabolism , Muscle, Smooth, Vascular/pathology , Myocytes, Smooth Muscle/pathology , Nuclear Proteins/metabolism , Phenotype , Signal Transduction , Stress Fibers/metabolism , Trans-Activators/metabolism , Transforming Growth Factor beta/metabolism , Vascular Remodeling , rhoA GTP-Binding Protein/metabolism , Calponins
3.
Eur Heart J Acute Cardiovasc Care ; 9(2): 128-137, 2020 Mar.
Article in English | MEDLINE | ID: mdl-30525871

ABSTRACT

BACKGROUND: Current guidelines recommend emergency surgical correction in patients with post infarction ventricular septal rupture (PIVSR), but patients with multiorgan failure are commonly managed conservatively because of high surgical risk. We assessed characteristics and outcomes of operated PIVSR patients with or without the use of short-term ventricular assist devices (ST-VADs). We also assessed the impact of a ST-VAD on the performance of surgery. METHODS: We retrospectively analysed all consecutive patients with PIVSR between January 2004 and May 2017. Baseline clinical characteristics, use of ST-VAD and performance of surgery during admission were assessed. The main outcome measured was in-hospital mortality. RESULTS: A total of 28 patients were included. Mean age was 69.2 years. Most patients (20/28, 71.4%) underwent surgical repair. ST-VADs were used in 11/28 patients (39.3%). This percentage progressively increased across the study period, from 22.2% (2/9) in 2004-2011 to 58.3% (7/12) in 2015-2017 (p=0.091). Patients undergoing ST-VAD use had poorer INTERMACS status, higher values of creatinine, lactate and alanine aminotransferase and lower left ventricular ejection fraction as compared with operated patients without support. In-hospital mortality did not differ according to the use of ST-VADs in operated patients (27.3% without ST-VAD vs. 22.2% with ST-VAD, p=0.604). All five patients undergoing early preoperative venoarterial extracorporeal membrane oxygenator support and delayed surgery survived at hospital discharge. CONCLUSIONS: ST-VAD use increased in patients with PIVSR. Despite a higher risk profile in operated patients undergoing ST-VAD use, mortality was not significantly different in these patients. Early preoperative venoarterial extracorporeal membrane oxygenation should be considered for very high risk PIVSR patients.


Subject(s)
Heart-Assist Devices/adverse effects , Myocardial Infarction/complications , Perioperative Care/methods , Shock, Cardiogenic/etiology , Ventricular Septal Rupture/complications , Aged , Aged, 80 and over , Alanine Transaminase/analysis , Case-Control Studies , Creatinine/blood , Extracorporeal Membrane Oxygenation/adverse effects , Extracorporeal Membrane Oxygenation/mortality , Female , Hospital Mortality/trends , Humans , Lactic Acid/blood , Male , Middle Aged , Multiple Organ Failure/complications , Practice Guidelines as Topic , Retrospective Studies , Risk Factors , Stroke Volume/physiology , Treatment Outcome , Ventricular Function, Left/physiology , Ventricular Septal Rupture/surgery
4.
Am J Surg ; 183(3): 256-60, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11943122

ABSTRACT

OBJECTIVE: Although diverticulitis is the most common cause of large bowel perforation, other disease may result in left colonic peritonitis. The aim of this study was to evaluate and compare the incidence, management, and outcome of patients with different causes of nondiverticular left colonic perforations. PATIENTS AND METHODS: From January 1992 to September 2000, 212 surgical patients underwent emergency operation for distal colonic peritonitis. Perforations were caused by diverticulitis in 133 patients (63%) and by a nondiverticular process in 79 (37%). Mortality and morbidity in patients with nondiverticular perforation of the distal large bowel its relationship with the general conditions, the grade and the cause of peritonitis were analysed. Four types of surgical procedures were used. Hartmann's procedure was performed in 40 patients (51%); intraoperative colonic lavage, resection, and primary anastomosis (ICL) in 27 patients (34%); colostomy in 7 (9%); and subtotal colectomy in 5 (6%). RESULTS: Perforated neoplasm, the most common cause of peritonitis, was observed in 30 patients, colonic ischemia in 20, iatrogenia in 13, and other causes in 16 patients. One or more complications were observed in 57 patients (72%); among causes of perforation, colonic ischemia was significantly associated with the longest hospital stay and highest mortality. Eighteen patients (23%) died. CONCLUSIONS: Left large bowel perforation by nondiverticular disease is associated with high mortality and morbidity. The prognosis of patients is determined by the development of septic shock and colonic ischemia, as underlying disease, may influence patient survival.


Subject(s)
Colonic Diseases/surgery , Intestinal Perforation/surgery , Peritonitis/surgery , Adult , Aged , Aged, 80 and over , Analysis of Variance , Anastomosis, Surgical , Chi-Square Distribution , Colectomy/methods , Colonic Diseases/complications , Colonic Diseases/mortality , Emergencies , Emergency Treatment/methods , Female , Humans , Intestinal Perforation/etiology , Intestinal Perforation/mortality , Male , Middle Aged , Peritonitis/complications , Peritonitis/mortality , Postoperative Complications/epidemiology , Probability , Retrospective Studies , Risk Assessment , Survival Rate , Treatment Outcome
6.
Cir. Esp. (Ed. impr.) ; 72(3): 125-131, sept. 2002. ilus
Article in Es | IBECS (Spain) | ID: ibc-14771

ABSTRACT

Introducción. Uno de los métodos actualmente empleados para aumentar el pool de injertos hepáticos disponibles es el trasplante hepático dominó (THD) o secuencial. En esta modalidad de trasplante hepático, se utiliza el órgano extraído en un paciente trasplantado a causa de una polineuropatía amiloidótica familiar (PAF) (donante "dominó") para implantarlo en otro receptor. Objetivo. El objetivo de este trabajo es la exposición de los aspectos más relevantes y característicos de la técnica quirúrgica en el THD. Pacientes y métodos. Se presentan los datos y resultados obtenidos en los 13 THD que nuestro grupo realizó entre febrero de 1999 y noviembre de 2001.Resultados. La hepatectomía en el paciente con PAF debe incluir la vena cava retrohepática con sección y ligadura de las venas diafragmáticas, mientras que el implante no presenta diferencias importantes con respecto a la técnica habitual. En tres casos los injertos obtenidos de los donantes "dominó" presentaban alguna variante de la normalidad en la vascularización arterial, que hizo necesaria la cirugía de banco. No se produjo mortalidad, ningún paciente ha presentado complicaciones atribuibles a la técnica y sólo en un caso fue necesario transfundir sangre durante el trasplante. En los receptores del THD se empleó la técnica de preservación de cava en todos los casos. La anastomosis arterial se realizó con el patch formado por la arteria gastroduodenal y la hepática común. Para la anastomosis de la cava superior se utilizaron las tres venas suprahepáticas del receptor en 9 casos y en otros dos fue necesario realizar una anastomosis directamente con la cava inferior. La mediana de transfusión fue de 3 ñ 2,5 (rango, 0-7) concentrados de hematíes. La única complicación técnica fue una estenosis de la anastomosis suprahepática. Conclusiones. El THD es una técnica segura que no aumenta el riesgo operatorio de los pacientes con PAF. Los aspectos técnicos más relevantes son: la obtención de una longitud suficiente de vena cava inferior y la identificación de las variantes anatómicas arteriales en el injerto del paciente con PAF (AU)


Subject(s)
Adult , Female , Male , Middle Aged , Humans , Liver Transplantation/methods , Hepatectomy/methods , Anastomosis, Surgical/methods , Arteriovenous Anastomosis/surgery , Biliary Fistula/surgery , Biliary Fistula/physiopathology , Tissue Donors
SELECTION OF CITATIONS
SEARCH DETAIL